A Phase 1, Open-label, Safety and Immunogenicity Study of a Booster Dose of the Investigational CV0501 mRNA COVID-19 Vaccine in Adults at Least 18 Years Old
Latest Information Update: 28 Jan 2025
Price :
$35 *
At a glance
- Drugs CV-0501 (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
- Sponsors GSK
- 28 Jan 2025 New trial record